Trial Profile
Comparative evaluation of immunogenicity of various schedules and delivery options to provide fractional Dose Inactivated Poliovirus Vaccine in routine immunization in the post tOPV-bOPV period: A multi-centric open label randomized controlled trial (India fractional dose IPV study) - WHO fIPV study
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 20 Jul 2020
Price :
$35
*
At a glance
- Drugs Poliovirus vaccine inactivated (Primary) ; Poliovirus vaccine inactivated (Primary) ; Poliovirus vaccine
- Indications Poliomyelitis
- Focus Pharmacodynamics
- Sponsors Panacea Biotec
- 07 Mar 2017 New trial record